Christopher Mirabelli - Net Worth and Insider Trading

Christopher Mirabelli Net Worth

The estimated net worth of Christopher Mirabelli is at least $2 Million dollars as of 2024-04-24. Christopher Mirabelli is the CEO, President, Chairman, 10% Owner of Leap Therapeutics Inc and owns about 707,710 shares of Leap Therapeutics Inc (LPTX) stock worth over $2 Million. Christopher Mirabelli is also the Director, 10% Owner of Proteostasis Therapeutics Inc and owns about 107,465 shares of Proteostasis Therapeutics Inc (PTI) stock worth over $119,286. Details can be seen in Christopher Mirabelli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Mirabelli has not made any transactions after 2019-02-05 and currently still holds the listed stock(s).

Transaction Summary of Christopher Mirabelli

To

Christopher Mirabelli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Mirabelli owns 11 companies in total, including Leap Therapeutics Inc (LPTX) , GlobeImmune Inc (GBIM) , and Proteostasis Therapeutics Inc (PTI) among others .

Click here to see the complete history of Christopher Mirabelli’s form 4 insider trades.

Insider Ownership Summary of Christopher Mirabelli

Ticker Comapny Transaction Date Type of Owner
LPTX Leap Therapeutics Inc 2019-02-05 director & 10 percent owner & CEO,Pres,Chairman of the Board
GBIM GlobeImmune Inc 2016-02-17 other: Former 10% Owner
PTI Proteostasis Therapeutics Inc 2016-02-17 director & 10 percent owner
TRVN Trevena Inc 2014-01-30 director & 10 percent owner
TLOG TetraLogic Pharmaceuticals Corp 2013-12-17 10 percent owner
RDUS Radius Health Inc 2011-05-17 10 percent owner
ALT Altimmune Inc 2009-07-28 10 percent owner
MTEM Molecular Templates Inc 2009-10-05 10 percent owner
CSII Cardiovascular Systems Inc 2006-06-27 10 percent owner
YMTX Yumanity Therapeutics Inc 2016-02-10 director & 10 percent owner
KA Kineta Inc 2016-02-10 director & 10 percent owner

Christopher Mirabelli Latest Holdings Summary

Christopher Mirabelli currently owns a total of 2 stocks. Among these stocks, Christopher Mirabelli owns 707,710 shares of Leap Therapeutics Inc (LPTX) as of February 5, 2019, with a value of $2 Million and a weighting of 95.07%. Christopher Mirabelli also owns 107,465 shares of Proteostasis Therapeutics Inc (PTI) as of February 17, 2016, with a value of $119,286 and a weighting of 4.93%.

Latest Holdings of Christopher Mirabelli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LPTX Leap Therapeutics Inc 2019-02-05 707,710 3.25 2,300,058
PTI Proteostasis Therapeutics Inc 2016-02-17 107,465 1.11 119,286

Holding Weightings of Christopher Mirabelli


Christopher Mirabelli Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Mirabelli has made a total of 0 transactions in Leap Therapeutics Inc (LPTX) over the past 5 years. The most-recent trade in Leap Therapeutics Inc is the acquisition of 57,143 shares on February 5, 2019, which cost Christopher Mirabelli around $999,999.

According to the SEC Form 4 filings, Christopher Mirabelli has made a total of 0 transactions in Proteostasis Therapeutics Inc (PTI) over the past 5 years. The most-recent trade in Proteostasis Therapeutics Inc is the acquisition of 18,750 shares on February 17, 2016, which cost Christopher Mirabelli around $3 Million.

Insider Trading History of Christopher Mirabelli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Mirabelli Trading Performance

GuruFocus tracks the stock performance after each of Christopher Mirabelli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Mirabelli is 47.69%. GuruFocus also compares Christopher Mirabelli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Mirabelli within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher Mirabelli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher Mirabelli

Average Return

58.73%

Average return per transaction

Outperforming Transactions

67%

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 28.47 47.69 102.12 58.73 -20.51 -11.69
Relative Return to S&P 500(%) 24.92 41.53 94.44 42.55 -36.43 -25.88

Christopher Mirabelli Ownership Network

Ownership Network List of Christopher Mirabelli

No Data

Ownership Network Relation of Christopher Mirabelli


Christopher Mirabelli Owned Company Details

What does Leap Therapeutics Inc do?

Who are the key executives at Leap Therapeutics Inc?

Christopher Mirabelli is the director & 10 percent owner & CEO,Pres,Chairman of the Board of Leap Therapeutics Inc. Other key executives at Leap Therapeutics Inc include Chief Scientific Officer Jason Baum , 10 percent owner Beigene, Ltd. , and VP & Head of Reg Affairs/Qual Christine Granfield .

Leap Therapeutics Inc (LPTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Leap Therapeutics Inc Insider Transactions

No Available Data

Christopher Mirabelli Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Mirabelli. You might contact Christopher Mirabelli via mailing address: 55 Cambridge Parkway, Suite 301, Cambridge Ma 02142.

Discussions on Christopher Mirabelli

No discussions yet.